Publications by authors named "Alison J Butt"

Claim this Profile
M
Microtubule-stabilizing properties of the avocado-derived toxins (+)-(R)-persin and (+)-(R)-tetrahydropersin in cancer cells and activity of related synthetic analogs.
Jessica J Field, Arun Kanakkanthara, Darby G Brooke, Saptarshi Sinha, Sushila D Pillai, Alison J Butt

Invest New Drugs· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Register4: an Australian web-enabled resource created by the National Breast Cancer Foundation to facilitate and accelerate cancer research.
John L Hopper, Carmel Apicella, Alison J Butt

Med J Aust· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the impact of National Breast Cancer Foundation-funded research.
Claire Donovan, Linda Butler, Alison J Butt, Teresa H Jones, Stephen R Hanney

Med J Aust· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
Brigid C Browne, Falko Hochgräfe, Jianmin Wu, Ewan K A Millar, Jane Barraclough, Alison J Butt

FEBS J· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and in vitro evaluation of analogues of avocado-produced toxin (+)-(R)-persin in human breast cancer cells.
Darby G Brooke, Elizabeth J Shelley, Caroline G Roberts, William A Denny, Robert L Sutherland, Alison J Butt

Bioorg Med Chem· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting response: identifying molecular determinants of endocrine response and resistance in breast cancer.
Alison J Butt

Expert Rev Endocrinol Metab· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming resistance: targeting the PI3K/mTOR pathway in endocrine refractory breast cancer.
Alison J Butt

Cancer Biol Ther· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell cycle machinery: links with genesis and treatment of breast cancer.
Alison J Butt, C Elizabeth Caldon, Catriona M McNeil, Alexander Swarbrick, Elizabeth A Musgrove

Adv Exp Med Biol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer.
Elizabeth A Musgrove, C Marcelo Sergio, Sherene Loi, Claire K Inman, Luke R Anderson, Alison J Butt

PLoS One· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome.
Alison J Butt, C Marcelo Sergio, Claire K Inman, Luke R Anderson, Catriona M McNeil

Breast Cancer Res· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of downstream targets of estrogen and c-myc in breast cancer cells.
Elizabeth A Musgrove, C Marcelo Sergio, Luke R Anderson, Claire K Inman, Catriona M McNeil, Alison J Butt

Adv Exp Med Biol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Live or let die: oestrogen regulation of survival signalling in endocrine response.
Alison J Butt, Robert L Sutherland, Elizabeth A Musgrove

Breast Cancer Res· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic cytotoxicity between tamoxifen and the plant toxin persin in human breast cancer cells is dependent on Bim expression and mediated by modulation of ceramide metabolism.
Caroline G Roberts, Ebru Gurisik, Trevor J Biden, Robert L Sutherland, Alison J Butt

Mol Cancer Ther· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
c-Myc overexpression and endocrine resistance in breast cancer.
Catriona M McNeil, C Marcelo Sergio, Luke R Anderson, Claire K Inman, Sarah A Eggleton, Alison J Butt

J Steroid Biochem Mol Biol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cells.
Alison J Butt, Caroline G Roberts, Alan A Seawright, Peter B Oelrichs, John K Macleod

Mol Cancer Ther· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancement of tumor necrosis factor-alpha-induced growth inhibition by insulin-like growth factor-binding protein-5 (IGFBP-5), but not IGFBP-3 in human breast cancer cells.
Alison J Butt, Kristie A Dickson, Stan Jambazov, Robert C Baxter

Endocrinology· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E.
Alison J Butt, Catriona M McNeil, Elizabeth A Musgrove, Robert L Sutherland

Endocr Relat Cancer· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: the role of altered epidermal growth factor signaling.
Alison J Butt, Janet L Martin, Kristie A Dickson, Fiona McDougall, Sue M Firth

J Clin Endocrinol Metab· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo.
Alison J Butt, Kristie A Dickson, Fiona McDougall, Robert C Baxter

J Biol Chem· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGF-binding protein-3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells.
Alison J Butt, Kristie A Fraley, Sue M Firth, Robert C Baxter

Endocrinology· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis